By age 85, the lifetime risk estimate of developing Alzheimer's Disease Dementia (ADD) is 60–70% for ε4/ε4 homozygotes and 20–30% for ε4/ε3 heterozygotes (ApoE carriers) (Genin et al., 2011). This evidence concerns the gene APOE and Alzheimer disease.